Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:7098987.
doi: 10.1155/2016/7098987. Epub 2016 Aug 28.

Embryoid Body-Explant Outgrowth Cultivation from Induced Pluripotent Stem Cells in an Automated Closed Platform

Affiliations

Embryoid Body-Explant Outgrowth Cultivation from Induced Pluripotent Stem Cells in an Automated Closed Platform

Hiroshi Tone et al. Biomed Res Int. 2016.

Abstract

Automation of cell culture would facilitate stable cell expansion with consistent quality. In the present study, feasibility of an automated closed-cell culture system "P 4C S" for an embryoid body- (EB-) explant outgrowth culture was investigated as a model case for explant culture. After placing the induced pluripotent stem cell- (iPSC-) derived EBs into the system, the EBs successfully adhered to the culture surface and the cell outgrowth was clearly observed surrounding the adherent EBs. After confirming the outgrowth, we carried out subculture manipulation, in which the detached cells were simply dispersed by shaking the culture flask, leading to uniform cell distribution. This enabled continuous stable cell expansion, resulting in a cell yield of 3.1 × 10(7). There was no evidence of bacterial contamination throughout the cell culture experiments. We herewith developed the automated cultivation platform for EB-explant outgrowth cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histology of teratoma generated by Edom-iPS#S23 cells. (a) Teratoma (low-power view). (b) Epidermis. (c) Immature neuroepithelium. (d) Intestinal epithelium. (e) Intestinal epithelium with goblet and Paneth cells (high-power view of panel (d)). (f) Smooth muscle.
Figure 2
Figure 2
Time-course images of teratoma-derived cells in automated culture. (a) Scheme for automated culture of teratoma-derived cells. ((b), (c), (d)) Phase-contrast photomicrography of day 1 (b), day 4 (c), and day 7 (d) after the start of the automated culture. The experiments were repeated four independent times. The scale bars indicate 500 μm.
Figure 3
Figure 3
Time-course images of keratinocytes in automated culture. (a) Scheme for automated culture of keratinocytes. ((b), (c), (d)) Phase-contrast photomicrography of day 1 (b), day 4 (c), and day 6 (d) after the start of the automated culture. The experiments were repeated three independent times. The scale bars indicate 500 μm.
Figure 4
Figure 4
Time-course images of iPSC-derived EB-explant outgrowth cells in automated culture. (a) Scheme for automated culture of EB-explant outgrowth cells. ((b), (c), (d), (e)) Phase-contrast photomicrography of day 1 (b), day 4 (c), day 8 (d), and day 23 (e) after the start of the automated culture. The EBs adhered to the culture surface (on day 1) and the cell outgrowth was clearly confirmed surrounding the EBs (on day 4), after which we performed the subculture manipulation (on day 7). The uniform cell distribution after passage could be confirmed by an image on day 8. The cells were cultured until reaching subconfluent state (on day 23). The experiments were repeated three independent times. The scale bars indicate 500 μm.

Similar articles

Cited by

References

    1. Tran C. A., Burton L., Russom D., et al. Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity. Journal of Immunotherapy. 2007;30(6):644–654. doi: 10.1097/cji.0b013e318052e1f4. - DOI - PubMed
    1. Mason C., Hoare M. Regenerative medicine bioprocessing: building a conceptual framework based on early studies. Tissue Engineering. 2007;13(2):301–311. doi: 10.1089/ten.2006.0177. - DOI - PubMed
    1. Okano T., Sawa Y., Barber E., Umezawa A. Regenerative therapy by fusion of medicine and engineering: first-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: a report of the Symposium of Regenerative Medicine for Patients. Regenerative Therapy. 2015;2:2–5. doi: 10.1016/j.reth.2015.07.002. - DOI - PMC - PubMed
    1. Kami D., Watakabe K., Yamazaki-Inoue M., et al. Large-scale cell production of stem cells for clinical application using the automated cell processing machine. BMC Biotechnology. 2013;13(1, article 102) doi: 10.1186/1472-6750-13-102. - DOI - PMC - PubMed
    1. Kato R., Iejima D., Agata H., et al. A compact, automated cell culture system for clinical scale cell expansion from primary tissues. Tissue Engineering Part C: Methods. 2010;16(5):947–956. doi: 10.1089/ten.tec.2009.0305. - DOI - PubMed

LinkOut - more resources